Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population.
(1/11)
(+info)
Genomewide association study of leprosy.
(2/11)
(+info)
Use of the ML-Flow test as a tool in classifying and treating leprosy.
(3/11)
(+info)
Profile of patients affected by Hansen's disease seen at the Outpatient Clinic of Dermatology at Hospital Evangelico de Curitiba.
(4/11)
(+info)
Epidemiological, clinical, and operational aspects of leprosy patients assisted at a referral service in the state of Maranhao, Brazil.
(5/11)
(+info)
Quality of life of patients with paucibacillary leprosy.
(6/11)
(+info)
Concordance between expected and observed bacilloscopy results of clinical forms of leprosy: a 6-year retrospective study in Recife, State of Pernambuco, Brazil.
(7/11)
(+info)
A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design.
(8/11)
(+info)